OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.11), $0.09 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $401.3 million versus the consensus estimate of $329.83 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.